Patent Applications
Marv Enterprises, LLC Patent Application Filings on Related Subject Matter
| Title | Patent/Application No. | Filing Date | Status |
|---|---|---|---|
| *Method for Treating and Curing Covid-19 Infection | US 62/989981 | 03/16/2020 | Provisional |
| *Method for Treating Covid-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in Covid-19 Patients | US 63/007207 | 04/08/2020 | Provisional |
| *Method for Treating and Curing Covid-19 Infection by Utilizing a Laser to Eradicate the Virus | US 63/013104 | 4/21/2020 | Provisional |
| *Nasal Spray To Prevent The Transmission Of Covid-19 Between Humans | US 63/080735 | 9/20/2020 | Provisional |
| Utilization of Stents for the Treatment of Blood Borne Carcinomas | US 13/128870 | 11/11/2009 | Issued Patent US 8,758,287 |
| Sequential Extracorporeal Treatment of Bodily Fluids | US 13/254855 | 3/16/2010 | Issued Patent US 9,216,386 |
Issued Patents
Sequential Extracorporeal Treatment of Bodily Fluids
U.S. Patent No. 9,216,386 — Issued December 22, 2015
An article and method to treat extracorporeally a patient’s bodily fluid. The bodily fluid can include blood, cerebral spinal fluid and lymph. A first stage of the method includes applying a treatment. The treatment can comprise dosing with a medication, thermal treatment, or irradiation. The treatment can occur at levels that could otherwise compromise the patient’s health. A second stage of the method substantially removes the treatment from the bodily fluid. The bodily fluid can then be returned to the patient. The article includes a treatment chamber that applies the treatment and a removal module for removing the treatment. The method can be a continuous process such as, for example, a dialysis process.
View the full patent here.
Utilization of Stents for the Treatment of Blood Borne Carcinomas
U. S. Patent No. 8,758,287 — Issued June 24, 2014
A filter and a method treat blood borne carcinomas by inducing apoptosis in carcinoma cells. The filter included comprises a stent having an interior wall defining a channel containing a packing material and at least one antineoplastic agent. The method includes placing a patient’s blood in apposition of the antineoplastic agent by pumping the blood through the stent. The blood remains in apposition to the antineoplastic agent for a sufficient time period to induce an apoptotic cascade. Save
View the full patent here.